SciClone Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

SCLN 10.43 +0.27 (2.61%)
price chart
Unable to Shed Weakness, Shares Still in a Downtrend: SciClone Pharmaceuticals ...
Shares of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) have been on a consistent downtrend as of late, causing concern for stock owners.
/quotes/zigman/3870025/realtime
SciClone Pharmaceuticals Inc. NASDAQ: SCLN. GO. Set Alerts · Find a Broker · Join TD Ameritrade · Market Index · Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) Spurns Buyout Offers
Those who pegged their hopes on SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) selling itself to cash in on the acquisition have turned up disappointed.
SciClone Pharmaceuticals Inc. (SCLN) Dropped After Strategic Review Concluded  RTT News
Stock Highlights: SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN), Intuitive ...  Benchmark Monitor
Why SciClone Pharmaceuticals, Inc. Is Surging Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Option Market: SciClone Pharmaceuticals Inc Risk Hits An Elevated Level
This is a proprietary risk rating for the next 30-days built by Capital Market Laboratories (CMLviz) based on a large number of interactions of data points, many of which come directly from the option market for SciClone Pharmaceuticals Inc (NASDAQ:SCLN) .
Reata Pharmaceuticals Inc versus SciClone Pharmaceuticals Inc Head to Head Compare
SciClone Pharmaceuticals Inc has a substantially higher fundamental rating then Reata Pharmaceuticals Inc which has an impact on the head-to-head comparison.
DOW JONES, A NEWS CORP COMPANY
News SciClone Pharmaceuticals Inc.SCLN. Significant News Only. 07/19/16; Press Release. SciClone Provides Update On Strategic Review Process.
SciClone Pharmaceuticals Inc versus Intersect ENT Inc Head to Head Compare
SciClone Pharmaceuticals Inc has a substantially higher fundamental rating then Intersect ENT Inc which has an impact on the head-to-head comparison.
SciClone Pharmaceuticals Inc. (SCLN) is Trading Higher on Unusual Volume for ...
SciClone Pharmaceuticals Inc. (SCLN) experienced unusually high volume on Jul. 21, as the stock gained 0.78% to a closing price of $10.37.
Distress Signals Prevail for Shares of SciClone Pharmaceuticals, Inc. (NASDAQ ...
Shares of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) have been on a consistent downtrend as of late, causing concern for stock owners.